Should a patient with hyperglycemia and type 2 diabetes mellitus, currently on insulin glargine, receive short-acting insulin?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Hyperglycemia in Hospitalized Patient with COPD and Type 2 Diabetes

Short-acting insulin should be added to the patient's regimen to manage hyperglycemia, as the patient has a blood glucose of 20.9 mmol/L (376 mg/dL) and is only on basal insulin (glargine 6 units). 1

Assessment of Current Situation

  • The patient is a 91-year-old male with COPD exacerbation and type 2 diabetes with severe hyperglycemia (20.9 mmol/L) 1
  • Currently only on 6 units of glargine (basal insulin) in the morning 1
  • Has elevated blood pressure (164/99), respiratory rate (22-24), and requires oxygen support (3L) 1

Rationale for Adding Short-Acting Insulin

  • For hospitalized patients with severe hyperglycemia (>300 mg/dL or >16.6 mmol/L), a basal-bolus insulin regimen is indicated 1
  • The patient's current blood glucose of 20.9 mmol/L (376 mg/dL) falls into the severe hyperglycemia category requiring more aggressive management 1
  • Basal insulin alone is insufficient for managing severe hyperglycemia in hospitalized patients, especially those with acute illness like COPD exacerbation 1

Recommended Insulin Regimen

  • Continue basal insulin (glargine) but consider increasing the dose to 0.2-0.3 units/kg/day based on weight 1
  • Add rapid-acting insulin before meals (or every 4-6 hours if not eating) 1
  • For severe hyperglycemia (>300 mg/dL), implement a basal-bolus regimen with approximately half the total daily dose as basal and half as prandial insulin 1
  • Initial prandial insulin dose can start at 4 units, 0.1 units/kg, or 10% of the basal dose before meals 1

Special Considerations for This Patient

  • The patient's COPD exacerbation represents a significant physiologic stress that can worsen hyperglycemia 1, 2
  • Advanced age (91 years) increases hypoglycemia risk, so careful monitoring is essential 1
  • The patient is on antibiotics (azithromycin and amoxiclav) for COPD exacerbation, which may affect glucose levels 1
  • Implement a hypoglycemia prevention and management protocol 1

Monitoring and Adjustment

  • For hospitalized patients who are eating, monitor blood glucose before meals 1
  • For patients not eating, monitor every 4-6 hours 1
  • Adjust insulin doses based on blood glucose patterns 1
  • Watch for signs of overbasalization (basal dose exceeding 0.5 units/kg/day, significant bedtime-to-morning glucose differential, hypoglycemia) 1

Common Pitfalls to Avoid

  • Using sliding scale insulin alone is strongly discouraged as it treats hyperglycemia reactively rather than preventively 1
  • Failure to adjust insulin doses based on nutritional intake can lead to hypoglycemia 1
  • Not considering the impact of COPD exacerbation and steroid treatment (if used) on glucose levels 1
  • Overlooking the need to monitor for hypoglycemia, especially in elderly patients 1

Transition Planning

  • Have a protocol for resuming oral medications 1-2 days before discharge if applicable 1
  • Ensure proper education and follow-up plans are in place before discharge 1
  • Consider long-term management needs based on pre-hospitalization diabetes control 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.